Rossi, B.; Nguyen, L.S.; Zimmermann, P.; Boucenna, F.; Dubret, L.; Baucher, L.; Guillot, H.; Bouldouyre, M.-A.; Allenbach, Y.; Salem, J.-E.;
et al. Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study. Pharmaceuticals 2020, 13, 317.
https://doi.org/10.3390/ph13100317
AMA Style
Rossi B, Nguyen LS, Zimmermann P, Boucenna F, Dubret L, Baucher L, Guillot H, Bouldouyre M-A, Allenbach Y, Salem J-E,
et al. Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study. Pharmaceuticals. 2020; 13(10):317.
https://doi.org/10.3390/ph13100317
Chicago/Turabian Style
Rossi, Benjamin, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, Helene Guillot, Marie-Anne Bouldouyre, Yves Allenbach, Joe-Elie Salem,
and et al. 2020. "Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study" Pharmaceuticals 13, no. 10: 317.
https://doi.org/10.3390/ph13100317
APA Style
Rossi, B., Nguyen, L. S., Zimmermann, P., Boucenna, F., Dubret, L., Baucher, L., Guillot, H., Bouldouyre, M.-A., Allenbach, Y., Salem, J.-E., Barsoum, P., Oufella, A., & Gros, H.
(2020). Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study. Pharmaceuticals, 13(10), 317.
https://doi.org/10.3390/ph13100317